Assessing the Risk of De Novo Malignancy in Kidney Transplant Recipients: Role for Monitoring of Peripheral Blood Lymphocyte Populations

被引：4
|
作者：
Fernandez-Ruiz, Mario [1 ]
Lopez-Medrano, Francisco [1 ]
Allende, Luis M. [2 ]
Andres, Amado [3 ]
Paz-Artal, Estela [2 ]
Maria Aguado, Jose [1 ]
机构：
[1] Hosp Univ 12 Octubre, Inst Invest, Infect Dis Unit, Madrid 28041, Spain
[2] Hosp Univ 12 Octubre, Inst Invest, Dept Immunol, Madrid 28041, Spain
[3] Hosp Univ 12 Octubre, Inst Invest, Dept Nephrol, Madrid 28041, Spain
来源：
TRANSPLANTATION | 2014年 / 98卷 / 05期
关键词：
CELL-DEPLETING ANTIBODIES; SUBSETS; CANCER;
D O I：
10.1097/TP.0000000000000297
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E36 / E37
页数：2
相关论文
共 50 条
  • [41] De novo renal cell carcinoma of native kidney in renal transplant recipients
    Neuzillet, Y
    Lay, F
    Luccioni, A
    Daniel, L
    Berland, Y
    Coulange, C
    Lechevallier, E
    CANCER, 2005, 103 (02) : 251 - 257
  • [42] Infections in de novo kidney transplant recipients treated with the RANKL inhibitor denosumab
    Bonani, Marco
    Frey, Diana
    De Rougemont, Olivier
    Mueller, Nicolas
    Mueller, Thomas
    Graf, Nicole
    Wuthrich, Rudolf
    SWISS MEDICAL WEEKLY, 2016, 146 : 7S - 7S
  • [43] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    TRANSPLANTATION, 2014, 98 : 672 - 672
  • [44] Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in de Novo Pediatric Kidney Transplant Recipients
    Zhao, Wei
    Elie, Valery
    Roussey, Gwenaelle
    Brochard, Karine
    Niaudet, Patrick
    Deschenes, Georges
    Cochat, Pierre
    Cloarec, Sylvie
    Andre, Jean Luc
    Tsimaratos, Michel
    Bensman, Albert
    Fakhoury, May
    Jacqz-Aigrain, Evelyne
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 662 - 662
  • [45] Advagraf® with or without an induction therapy for de novo kidney-transplant recipients
    Noble, Johan
    Jouve, Thomas
    Rostaing, Lionel
    Malvezzi, Paolo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (06) : 461 - 467
  • [46] Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
    Zhao, W.
    Elie, V.
    Roussey, G.
    Brochard, K.
    Niaudet, P.
    Leroy, V.
    Loirat, C.
    Cochat, P.
    Cloarec, S.
    Andre, J. L.
    Garaix, F.
    Bensman, A.
    Fakhoury, M.
    Jacqz-Aigrain, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (06) : 609 - 618
  • [47] Effect of denosumab on trabecular bone score in de novo kidney transplant recipients
    Bonani, Marco
    Frey, Diana
    Graf, Nicole
    Wuthrich, Rudolf P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (10) : 1773 - 1780
  • [48] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 672 - 672
  • [49] Racial Differences in Tacrolimus Xr Dosing in De Novo Kidney Transplant Recipients
    Patel, N.
    Carcella, T.
    Bartlett, F.
    Rohan, V.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 818 - 818
  • [50] Analysis of Predictive and Preventive Factors for De Novo DSA in Kidney Transplant Recipients
    Hirai, Toshihito
    Furusawa, Miyuki
    Omoto, Kazuya
    Ishida, Hideki
    Tanabe, Kazunari
    TRANSPLANTATION, 2014, 98 (04) : 443 - 450
12345